Zenas BioPharma (ZBIO) Capital Expenditures (2024 - 2026)
Zenas BioPharma's (ZBIO) quarterly Capital Expenditures came in at $2000.0 in Q1 2026, down 88.89% year-on-year from $18000.0 in Q1 2025, and down 88.89% quarter-over-quarter from $18000.0 in Q1 2025.
Zenas BioPharma (ZBIO) Capital Expenditures (2024 - 2026) Analysis & Trends
Zenas BioPharma's Capital Expenditures history runs 3 years deep, the most recent figure standing at $2000.0 for Q1 2026.
- On a quarterly basis, Capital Expenditures fell 88.89% year-over-year to $2000.0 in Q1 2026; TTM through Mar 2026 was $2000.0, a 98.43% decrease from a year earlier, with the FY2025 full-year figure at $18000.0, down 86.26% from the prior year.
- Capital Expenditures eased to $2000.0 in Q1 2026 per ZBIO's latest filing, from $18000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $74000.0 in Q4 2024 and bottomed at $2000.0 in Q1 2026.
- The 3-year median for Capital Expenditures is $22000.0 (2024), against an average of $30200.0.
- Across the five-year window, Capital Expenditures dropped 18.18% in 2025 and tumbled 88.89% in 2026, its largest moves.
- Year by year, Capital Expenditures stood at $74000.0 in 2024, then slumped by 75.68% to $18000.0 in 2025, then tumbled by 88.89% to $2000.0 in 2026.
- Per Business Quant, the three latest ZBIO Capital Expenditures figures stand at $2000.0 (Q1 2026), $18000.0 (Q1 2025), and $74000.0 (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Zenas BioPharma | 1.72 Bn | 1.72 Bn | - | 2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,000.00 |
| Mar 31, 2026 | 2,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | 74,000.00 |
| Dec 31, 2024 | 74,000.00 |
| Jun 30, 2024 | 35,000.00 |
| Jun 30, 2024 | 35,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Mar 31, 2024 | 22,000.00 |